Safety Study of MGD009 in B7-H3-expressing Tumors

Clinical trial NCT02628535 · TERMINATED

Trial details

NCT number: NCT02628535
Sponsor: MacroGenics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Mesothelioma Bladder Cancer Melanoma Squamous Cell Carcinoma of the Head and Neck Non Small Cell Lung Cancer Clear Cell Renal Cell Carcinoma Ovarian Cancer Thyroid Cancer Breast Cancer Pancreatic Cancer Prostate Cancer Colon Cancer

Start date: 2015-09-01
Primary completion: 2019-11-25
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.